As Vice President of Consultant Relations at Prime Therapeutics (Prime) and Magellan Rx, Ann O’Brien is responsible for developing and fostering relationships with national and regional health benefits consultants, positioning Prime Therapeutics as the premiere PBM (Pharmacy Benefit Management) of choice. O’Brien has more than 30 years of experience in the healthcare industry, 20 years of which have been focused within the pharmaceutical industry. Prior to joining Prime Therapeutics, O’Brien held leadership roles at Walgreens, Gilead Sciences, Sandoz, and Acorda Therapeutics.